These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17208143)

  • 1. Chemotherapy for muscle-invasive bladder cancer in the perioperative setting: current standards.
    Dreicer R
    Urol Oncol; 2007; 25(1):72-5. PubMed ID: 17208143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.
    Garcia JA; Dreicer R
    Nat Clin Pract Urol; 2005 Jan; 2(1):32-7. PubMed ID: 16474574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.
    Pectasides D; Pectasides M; Nikolaou M
    Eur Urol; 2005 Jul; 48(1):60-7; discussion 67-8. PubMed ID: 15967253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN
    Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
    Rosenberg JE
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1729-36. PubMed ID: 18062747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy in patients with invasive bladder cancer.
    Vaughn DJ; Malkowicz SB
    Urol Clin North Am; 2005 May; 32(2):231-7. PubMed ID: 15862620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
    CalabrĂ² F; Sternberg CN
    Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
    Izawa JI; Chin JL; Winquist E
    Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.
    Smith MR; Kantoff PW
    Semin Oncol; 1995 Dec; 22(6):625-32. PubMed ID: 8539637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative chemotherapy for bladder cancer.
    Sonpavde G; Petrylak DP
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):133-44. PubMed ID: 15990329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant chemotherapy for invasive bladder cancer].
    Kageyama Y; Kihara K
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer.
    Dreicer R
    Semin Urol Oncol; 2001 Aug; 19(3):180-5. PubMed ID: 11561985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
    Milowsky MI; Stadler WM; Bajorin DF
    BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perioperative strategies in patients with muscle invasive bladder cancer].
    Pouessel D; Thariat J; Lagrange JL; Mottet N; Culine S
    Bull Cancer; 2010; 97 Suppl Cancer de la vessie():5-9. PubMed ID: 20534384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
    Clark PE
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):821-30. PubMed ID: 19496719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining optimal therapy for muscle invasive bladder cancer.
    Herr HW; Dotan Z; Donat SM; Bajorin DF
    J Urol; 2007 Feb; 177(2):437-43. PubMed ID: 17222605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining surgery and chemotherapy for invasive bladder cancer: current and future directions.
    Amiel GE; Lerner SP
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):281-91. PubMed ID: 16445380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trials of adjuvant and neoadjuvant chemotherapy in bladder cancer.
    Dimopoulos MA; Galani E
    Semin Urol Oncol; 2001 Feb; 19(1):59-65. PubMed ID: 11246736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.